| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/29/2006 | CN1247260C Analogs of parathyroid hormone |
| 03/29/2006 | CN1247255C Preparation of biochemical nutrients for ostrich |
| 03/29/2006 | CN1247254C Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 03/29/2006 | CN1247251C Hyperlipemia treating medicine |
| 03/29/2006 | CN1247241C Liuwei Dihuang dripping pills |
| 03/29/2006 | CN1247234C Medicine for treating children's microelement deficiency and its processing method |
| 03/29/2006 | CN1247224C Application of opium seed in medicine for preparing diabetes |
| 03/29/2006 | CN1247220C Health care product of bee glue |
| 03/29/2006 | CN1247207C Production method of health-care food with auxiliary action for curing diabetos |
| 03/29/2006 | CN1247206C Health-care food and its production method |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247201C Use of ribose to prevent cramping and soreness in muscles |
| 03/29/2006 | CN1247199C Nutrition supplement agent |
| 03/29/2006 | CN1247198C Composition for treating hyperlipemia |
| 03/29/2006 | CN1247196C Solid prepn. of sodium vitamin C for injection and its prepn. method |
| 03/29/2006 | CN1247194C Nagelinai clathrate compound |
| 03/29/2006 | CN1247179C Method for producing solid oral preparation form with continuous released active components |
| 03/28/2006 | USRE39050 Treating post-menopausal osteoporosis with raloxifene, formerly keoxifene, or raloxifene hydrochloride; new usage |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018982 Methods useful in the treatment of bone resorption diseases |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031375A2 Use of intradiscally administered autologous cells producing type i interferon for the treatment of degenerative disc disease |
| 03/23/2006 | WO2006031337A2 Combinations of pkc activators and pkc inhibitors for alzheimer’s disease treatment and cognitive enhancement |
| 03/23/2006 | WO2006030929A1 Carbohydrase inhibitors derived from chestnut and use thereof |
| 03/23/2006 | WO2006030898A1 Aldose reductase inhibitor |
| 03/23/2006 | WO2006030847A1 Novel bicyclic pyrazole derivative |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006030761A1 Novel diabetes-associated factor |
| 03/23/2006 | WO2006030303A1 Oral extended release dosage form comprising a high dose biguanide and a low dose sulfonylurea |
| 03/23/2006 | WO2006029769A1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments |
| 03/23/2006 | WO2006029728A1 ICA512 COUPLES INSULIN SECRETION AND GENE EXPRESSION IN β-CELLS |
| 03/23/2006 | WO2006029634A2 Pharmaceutical compositions containing insulin and insulinotropic peptide |
| 03/23/2006 | WO2005046658A3 Methods of modulating angiogenesis and cancer cell proliferation |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063839 Inhibitors of decrease in body temperature |
| 03/23/2006 | US20060063838 Activators of peroxisome proliferator-activated receptors |
| 03/23/2006 | US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063762 Indole indazole and benzazole derivative |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
| 03/23/2006 | US20060063717 Novel inhibitor of beta amyloid cleavage |
| 03/23/2006 | US20060063711 Use of sglt homolog |
| 03/23/2006 | US20060063702 Neuromedin U 2 receptor agonists and uses thereof |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060062862 Cholesterol-reducing agent made of dietary fibre and cholesterol-reducing substances |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | DE102004046012A1 New D-glucopyranosylphenyl-substituted cyclic compounds useful as sodium-dependent glucose cotransporter inhibitors for treating metabolic diseases, e.g. diabetes |
| 03/23/2006 | DE102004039509A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 03/23/2006 | DE102004036314A1 New D-glucopyranosylphenyl-substituted cyclic compounds useful as sodium-dependent glucose cotransporter inhibitors for treating metabolic diseases, e.g. diabetes |
| 03/23/2006 | CA2620208A1 Methods and compositions for the treatment of hyperlipidemia |
| 03/23/2006 | CA2580537A1 Compositions and their uses for lysosomal enzyme deficiencies |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580460A1 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia |
| 03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
| 03/23/2006 | CA2580135A1 7-azaindoles and their use as ppar agonists |
| 03/23/2006 | CA2578940A1 Ica512 couples insulin secretion and gene expression in .beta.-cells |
| 03/23/2006 | CA2576294A1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments |
| 03/23/2006 | CA2575788A1 Combination of pkc activators and pkc inhibitors for alzheimer's diseasetreatment and cognitive enhancement |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637539A1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 03/22/2006 | EP1637532A1 Fused pyrimidine derivative |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637522A1 Substituted pyrazoline compounds for reducing triglycerides in blood |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637159A1 Immunocompetent cell activation inhibitor and use thereof |
| 03/22/2006 | EP1637156A1 Systemic administration of osteogenic proteins in the treatment of metabolic bone diseases |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636218A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/22/2006 | EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1636205A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors |
| 03/22/2006 | EP1636201A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1636198A1 Aniline derivatives |
| 03/22/2006 | EP1636197A1 Novel 3-substituted-1,4-benzodiazepines |
| 03/22/2006 | EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1636188A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1636187A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase |